Wendell Wierenga, Director at CYTOKINETICS INC (CYTK), sold 20,000 shares at $66.14 ($1.3M) on 2025-12-22, disclosed to the SEC on 2025-12-23.
Scheduled sale ($1.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |